Research Explorer

Your browser does not support JavaScript or JavaScript is not enabled. Without JavaScript some functions of this webapplication may be disabled or cause error messages. To enable JavaScript, please consult the manual of your browser or contact your system administrator.

Project

Development of a live biotherapeutic medicine against colorectal cancer metastasis.

Outputs and Outcomes

Acronym

QuoBiCoR

Code

F2020/IOF-StarTT/132

Duration

01 January 2021 → 30 September 2024

Funding

Regional and community funding: Industrial Research Fund

Promotor

Bart De Spiegeleer

Research disciplines

Medical and health sciences
- Cancer therapy

Keywords

Live biotherapeutic geneesmiddel colorectale cancer metastasen Enterococcus faecium

Project description

In this study, a live biotherapeutic product containing selected Enterococcus faecium strains will be evaluated for its therapeutic and prophylactic adjuvant use in patients with (an increased risk of) colorectal cancer, to reduce metastasis progression.

English

Dutch

English

Cookie settings

In addition to functional cookies which are necessary for the website to function, Ghent University uses non-functional cookies such as statistical cookies and social media cookies. These non-functional cookies can also be placed by third parties, for example to measure the use of the site or to share content on social media. Certain media are only available if you accept the cookies. You can set and modify your cookie preferences yourself. Find out what cookies we use and why in the Cookie Statement.

Analytics

AnalyticsWe'll collect information about your visit to our site. It helps us understand how the site is used – what's working, what might be broken and what we should improve.

Powered by